Could a simple supplement boost knee injection results for arthritis sufferers?

NCT ID NCT07680101

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether adding an oral supplement (PEA) to a series of knee injections (adelmidrol and hyaluronic acid) can better reduce pain and improve function in people with knee arthritis. The injections aim to protect the joint from damage, while the supplement may help calm nerve-related inflammation. The trial involves 80 adults with knee osteoarthritis or rheumatoid arthritis who will receive either the injections alone or the injections plus the oral supplement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Adelmidrol 2% / Hyaluronic Acid 1% (injection) and micronized/ultramicronized Palmitoylethanolamide (oral supplement)

What this could lead to

If successful, this combination could offer a new way to ease knee pain and improve mobility for people with osteoarthritis or rheumatoid arthritis.

What could go wrong

This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The supplement may not provide added benefit over the injection alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neuroinflammatory Diseases osteoarthritis susceptibility 6 osteoarthritis, knee rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Azienda Ospedaliera Universitaria Integrata Verona

    Verona, Italy

    Contact Email: •••••@•••••